🇺🇸 FDA

Drug profile · INN

clarithromycin

CLARITHROMYCIN

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

clarithromycin (CLARITHROMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN clarithromycin
Brand CLARITHROMYCIN
Route ORAL
Formulation FOR SUSPENSION
Originator Sunshine Biopharma

Related patents

Search patents →

  1. US 11090326

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10143702

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9314477

    Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 6987175

    Processes for preparing clarithromycin polymorphs

    Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6812216

    11-C-substituted derivatives of clarithromycin

    Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6624292

    Processes for preparing clarithromycin polymorphs

    Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6599884

    Processes for preparing clarithromycin polymorphs and novel polymorph IV

    Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is clarithromycin?

clarithromycin (CLARITHROMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for clarithromycin?

CLARITHROMYCIN is a marketed brand name for clarithromycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of clarithromycin?

clarithromycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.